SPRY vs VOGX: stock comparison and AI forecast
Ars Pharmaceuticals, Inc. (SPRY) and Vogenx, Inc. (VOGX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
SPRY Ars Pharmaceuticals, Inc.
- Market Cap
- $303M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VOGX Vogenx, Inc.
- Price
- $19.92 -41.6% · 6M
- Market Cap
- $296M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- SPRY and VOGX have similar market capitalizations ($303M and $296M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | SPRY | VOGX |
|---|---|---|
| Market Cap | $303M | $296M |
| P/B Ratio | 24.24x | – |
| EPS | $-1.91 | – |
| Book Value/Share | $0.13 | – |
| Revenue/Share | $1.26 | – |
| FCF/Share | $-1.98 | – |
Profitability & Margins
| Metric | SPRY | VOGX |
|---|---|---|
| ROE | -1721.8% | – |
| ROA | -86.3% | – |
| ROIC | -114.7% | – |
| Operating Margin | -173.2% | – |
| Net Margin | -172.5% | – |
| EBT Margin | -166.7% | – |
Financial Health
| Metric | SPRY | VOGX |
|---|---|---|
| Current Ratio | 3.48x | 0.44x |
| Quick Ratio | 2.97x | – |
| D/E Ratio | 18.94x | – |
| Financial Leverage | 19.94x | – |
| Interest Coverage | -26.4x | – |
| Working Capital | $151M | -$2M |
Cash Flow
| Metric | SPRY | VOGX |
|---|---|---|
| Operating Cash Flow | -$196M | – |
| Free Cash Flow | -$197M | – |
| Capital Spending | -$200K | – |
| FCF/Sales | -157.4% | – |
| CapEx/Sales | 0.2% | – |
Operational Efficiency
| Metric | SPRY | VOGX |
|---|---|---|
| Asset Turnover | 0.50x | – |
| Receivables Turnover | 2.7x | – |
| Fixed Assets Turnover | 59.9x | – |
| Days Sales Outstanding | 137 days | – |
Income Statement
| Metric | SPRY | VOGX |
|---|---|---|
| Total Revenue | $125M | – |
| Operating Income | -$216M | – |
| Net Income | -$215M | – |
| R&D Expense | $15M | – |
| SG&A Expense | $284M | – |
Dividend & Shareholder Information
| Metric | SPRY | VOGX |
|---|---|---|
| Shares Outstanding | 99M | 15M |
SPRY vs VOGX: stock comparison and AI forecast
Which is bigger, SPRY or VOGX?
SPRY and VOGX have similar market capitalizations ($303M and $296M).
Which one does Intratio's AI model rank higher, SPRY or VOGX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.